Microbiological Evaluation of the Ocular Flora Before Cataract Surgery
Evaluation of Ocular Flora in Patients Undergoing Cataract Surgery. An Observational Study
1 other identifier
observational
120
1 country
1
Brief Summary
The purpose of the present study is to elucidate the spectrum of ocular flora and their antimicrobial susceptibility profiles in patients undergoing routine cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 23, 2014
CompletedFirst Posted
Study publicly available on registry
April 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedResults Posted
Study results publicly available
September 29, 2015
CompletedJanuary 18, 2016
December 1, 2015
6 months
April 23, 2014
July 20, 2015
December 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive Culture in Subjects Scheduled for Cataract Surgery
Number of participants with positive culture at the screening visit
At least 14 days before surgery
Secondary Outcomes (2)
Antibiotic Susceptibility
At least 14 days before surgery
Eradication Rate
Day of surgery
Study Arms (1)
single group
Patients undergone cataract surgery
Eligibility Criteria
Patients undergoing routine cataract surgery
You may qualify if:
- Patients scheduled for cataract surgery
- Age \> 18 years
- Any gender and race
- Willing to sign informed consent
You may not qualify if:
- Any antibiotics within 3 months
- Any ocular infection within 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SIFI SpAlead
Study Sites (1)
Casa di Cura Di Stefano
Catania, Catania, 95100, Italy
Biospecimen
Conjunctival and palpebral swab of the eye undergoing surgery
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr.Marcello Santocono
- Organization
- Casa di Cura Di Stefano
Study Officials
- PRINCIPAL INVESTIGATOR
Marcello Santocono, MD
Casa Di Cura Di Stefano Catania (Italy)
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2014
First Posted
April 28, 2014
Study Start
April 1, 2014
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
January 18, 2016
Results First Posted
September 29, 2015
Record last verified: 2015-12